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Abstract Unrepaired DNA damage during embryonic development can be potentially inherited
by a large population of cells. However, the quality control mechanisms that minimize the
contribution of damaged cells to developing embryos remain poorly understood. Here, we
uncovered an ATR- and CHK1-mediated transcriptional response to replication stress (RS) in mouse
embryonic stem cells (ESCs) that induces genes expressed in totipotent two-cell (2C) stage
embryos and 2C-like cells. This response is mediated by Dux, a multicopy retrogene defining the
cleavage-specific transcriptional program in placental mammals. In response to RS, DUX triggers
the transcription of 2C-like markers such as murine endogenous retrovirus-like elements (MERVL)
and Zscan4. This response can also be elicited by ETAA1-mediated ATR activation in the absence
of RS. ATR-mediated activation of DUX requires GRSF1-dependent post-transcriptional regulation
of Dux mRNA. Strikingly, activation of ATR expands ESCs fate potential by extending their
contribution to both embryonic and extra-embryonic tissues. These findings define a novel ATR
dependent pathway involved in maintaining genome stability in developing embryos by controlling
ESCs fate in response to RS.
Introduction
ESCs are characterized by self-renewal and the ability to propagate for several cycles in vitro and in
vivo (Giachino et al., 2013). Even if ESCs exhibit several markers of RS (Ahuja et al., 2016), they are
able to maintain genome integrity more efficiently than differentiated cells (Giachino et al., 2013).
The mechanisms underlying such distinctive feature are largely unknown.
ESC colonies harbor a small transient subpopulation of cells (2C-like cells) with functional and
transcriptional features of totipotent 2C-stage embryos (Choi et al., 2017; Ishiuchi et al., 2015;
Macfarlan et al., 2012). Transition to 2C-like cells has been shown to promote maintenance of
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genome integrity and survival of ESCs in long-term culture (Akiyama et al., 2015; Nakai-
Futatsugi and Niwa, 2016; Zalzman et al., 2010). In addition, several studies have demonstrated
that transition to the 2C-like state confers expanded developmental potential to ESCs, making them
capable of contributing to both embryonic and extra-embryonic tissues (also referred to as bidirec-
tional cell fate potential) (Choi et al., 2017; Ishiuchi et al., 2015; Macfarlan et al., 2012). However,
the molecular players underlying the transition to the 2C-like state in ESC culture and its possible
physiological relevance in vivo in maintaining genome integrity and expanding cell fate potential in a
developing embryo are not fully understood.
Here we provide several lines of evidence that ATR and CHK1-mediated response to RS triggers
the activation of 2C-specific genes in ESCs and mouse embryos. This transition is hampered in ESCs
derived from ATR-deficient Seckel and CHK1 haploinsufficient mouse models and following ATR or
CHK1 inhibition. Significantly, we show that ETAA1-mediated ATR activation is sufficient to trigger
the formation of 2C-like cells in the absence of RS.
Mechanistically, ATR-induced transition to 2C-like state is mediated by post-transcriptional regu-
lation of the Dux gene, which shapes the transcriptional signature of 2C-like cells and totipotent 2C-
stage embryos in placental mammals (De Iaco et al., 2017; Hendrickson et al., 2017;
Whiddon et al., 2017). ATR-dependent regulation of Dux requires the GSRF1 protein, which directly
binds to Dux mRNA promoting its stability. Importantly, activation of ATR promotes DUX-depen-
dent formation of placental trophoblast giantlike cells (TGCs), which is hampered in ATR-deficient
Seckel ESCs. Consistent with this, unlike Dux KO ESCs, ATR activation in WT ESCs lead to expanded
cell fate potential in vivo, as shown by their ability to contribute to both inner cell mass and extra-
embryonic compartments.
Results
RS increases the number of 2C-like cells in ESCs culture and activates
the expression of 2C-like genes in mouse embryos
Maintenance of genome stability along with unlimited self-renewal is a unique feature of ESCs
(Giachino et al., 2013). To understand how ESCs coordinate these functions, first we asked how
ESCs transcriptionally respond to RS at the single cell level. To this end, we performed single cell
transcriptional profiling (Macosko et al., 2015) of E14 mouse ESCs cultivated in Leukemia Inhibitory
Factor (LIF) plus MEK and GSK inhibitors (2i) upon treatment with aphidicolin (APH), a reversible
inhibitor of DNA polymerases that activates ATR by stalling replication forks progression (Aze et al.,
2016). Unsupervised clustering analysis of CNTL and APH-treated cells (Macosko et al., 2015) iden-
tified a distinct subset of cells (Figure 1a, Cluster 4; supplementary file 1), that was also clearly sep-
arated by Principal Component (PC) one from the rest of the population (Figure 1—figure
supplement 1a and b; supplementary file 1). The analysis of differentially expressed genes (DEGs)
between cluster four and the rest of the population identified a significant enrichment of 2C-specific
genes in this cluster, including Eif1a-like genes (Gm5662, Gm2022, Gm4027, Gm2016, and
Gm8300), Tcstv3, and Zscan4 genes (Zscan4a–Zscan4d), (Figure 1b and c; Figure 1—figure supple-
ment 1c and d; supplementary file 1 and 2), the transcription of which has been shown to play a
critical role in maintaining ESCs genome stability (Akiyama et al., 2015; Nakai-Futatsugi and Niwa,
2016; Zalzman et al., 2010). Remarkably, we found a statistically significant increase in the number
of cells expressing 2C-specific markers upon RS (Figure 1d; supplementary file 1). To understand
whether the increase in the number of 2C-like cells was a response to RS or it was limited to APH
treatment, we exposed pZscan4-Emerald ESCs generated by the stable introduction of the Emerald-
GFP reporter under the Zscan4c promoter (Zalzman et al., 2010) to a range of RS-inducing agents,
including APH, hydroxyurea (HU) and ultraviolet light (UV) (Cimprich and Cortez, 2008). Fluores-
cence Activated Cell Sorting (FACS) analysis confirmed a significant increase in the number of Emer-
ald positive (Em+) ESCs across all treated conditions in a dose-dependent manner
(Figure 1e; Figure 1—source data 1). Of note, the increase in the number of Em+ ESCs upon short
exposure to UV revealed that the continuous presence of the RS-inducing agent was not necessary
for the activation of 2C-like cells (Figure 1e; Figure 1—source data 1), suggesting that replication
fork stalling induced by UV-mediated DNA lesions was sufficient to trigger this pathway. Next, to
uncover the minimum timing required for the activation of ZSCAN4, we performed a time-course
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Figure 1. Induction of RS increases the number of 2C-like cells in ESCs culture and activates the expression of 2C-specific genes in mouse embryos.
(a) Clustering of 1399 Drop-seq single-cell expression profiles into four cell populations. The plot shows a two-dimensional representation (t-SNE) of
global gene expression relationship; cells are colored according to their cluster. Clusters were identified by shared nearest neighbor algorithm (see
methods). (b) t-SNE plot showing Zscan4d expression level across all CNTL and APH-treated cells. (c) Heatmap showing the list of top 30 genes that are
Figure 1 continued on next page
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experiment in which ESCs were treated with APH and subsequently harvested at various time points.
Immunoblot on ESCs revealed a rapid phosphorylation of CHK1 while a significant increase in
ZSCAN4 protein took place after 4–8 hr of treatment with APH (Figure 1—figure supplement 1e;
Figure 1—source data 1). Importantly, although APH, mostly at a high concentration, induced mild
cell apoptosis, the majority of Em+ cells were not co-stained with the apoptosis marker CASPASE-3,
suggesting that the emergence of Em+ cells upon APH treatment was not due to the activation of
apoptosis (Figure 1—figure supplement 1f). Moreover, no sign of cellular senescence was detected
by b-galactosidase staining upon APH treatment in ESCs (Figure 1—figure supplement 1g).
Due to the key role of DUX and MERVL-derived long terminal repeat (LTR) elements in shaping
the transcriptional signature of 2C-stage embryos and 2C-like cells (Choi et al., 2017; Ishiuchi et al.,
2015; Macfarlan et al., 2012; De Iaco et al., 2017; Hendrickson et al., 2017; Whiddon et al.,
2017), we next asked whether RS-induced expression of the Zscan4 gene was accompanied by the
activation of these retroelements. The RT-qPCR results revealed a linear correlation between con-
centration of RS inducing agents and the expression of key 2C-like markers, such as Dux, MERVL,
Zscan4d, Tcstv3, Gm12794, Gm4340 (Figure 1—figure supplement 2a–f; Figure 1—source data
1). These results were further validated using pMERVL-GFP ESCs (ESCs expressing a GFP reporter
under the control of MERVL promoter Ishiuchi et al., 2015; De Iaco et al., 2017; Figure 1—figure
supplement 2g and h; Figure 1—source data 1). However, induction of RS did not affect the
expression of main 2C-specific markers such as MERVL and Zscan4 (no expression was detected by
qPCR) in two mouse embryonic fibroblast (MEF) lines with distinct genetic backgrounds (C57BL/6J
and 129P2/OlaHsd) (Figure 1—figure supplement 2i; Figure 1—source data 1), suggesting the
involvement of alternative repressive mechanisms that suppress the activation of 2C-like transcrip-
tional program in more differentiated cells.
2C-like cells reduce the expression of pluripotency markers at protein but not transcriptional level
(Choi et al., 2017; Ishiuchi et al., 2015; Macfarlan et al., 2012). Thus, to understand whether RS-
induced cells share such feature with 2C-like cells, we monitored the expression of canonical pluripo-
tency markers upon APH treatment. In agreement with previous findings (Choi et al., 2017;
Ishiuchi et al., 2015), we detected downregulation of SOX2, and POU5F1 (also known as OCT4)
proteins in ZSCAN4+/Em+ cells by immunostaining and immunoblotting (Figure 1f; Figure 1—fig-
ure supplement 2j and k; Figure 1—source data 1). However, no significant alteration in the
expression of pluripotency-related genes (e.g., Nanog, Oct4 and Rex1) was observed at the tran-
scriptional level (Figure 1—figure supplement 2l–n; Figure 1—source data 1). As previously
reported (Ishiuchi et al., 2015), 2C- like cells that were identified by expression of 2C markers,
MERVL-GAG and ZSCAN4, and the absence of OCT4 protein, were found to lack chromocenters
(Figure 1—figure supplement 2j).
The ZSCAN4+/MERVL+ cells were reported to be present in all phases of the cell cycle albeit with
higher percentage in G2/M phase (Eckersley-Maslin et al., 2016). Of note, the cell cycle analysis on
pZscan4-Emerald ESCs confirmed that APH treatment neither at low (0.3 mM) nor at high (6 mM) con-
centration could increase the G2/M population in culture (Figure 1—figure supplement 3a). Similar
results were obtained upon exposure of ESCs to UV (Figure 1—figure supplement 3b), indicating
that the increase in the Em+ population upon APH and UV treatment was not due to cell cycle arrest
in G2/M. This is consistent with a previous work showing that G2/M arrest by nocodazole is not
Figure 1 continued
differentially expressed between cluster 4 cells (orange cluster in a) and the rest of the population (cluster 1,2, and 3). (d) Plot showing the scaled
expression of 2C-specific markers and the percentage of cells expressing 2C-related genes in CNTL and APH-treated condition. Fisher’s exact test was
used to determine p-values. (e) FACS analysis on pZscan4-Emerald ESCs upon treatment with various RS-inducing agents. (f) Immunostaining of ESCs
for ZSCAN4-Emerald, MERVL-GAG and canonical pluripotency marker POU5F1 upon treatment with APH (bar = 25 mm). (g–j) RT-qPCR analysis on
blastocyst-stage embryos treated with APH for key 2C-like markers. Statistical significance compared to CNTL unless otherwise indicated. All bar-plots
show mean with ± SD (*p0.05, **p0.01, ***p0.001, ****p0.0001, one-way ANOVA).
The online version of this article includes the following source data and figure supplement(s) for figure 1:
Source data 1. FACS, qPCR and Western quantification.
Figure supplement 1. Induction of RS increases the number of 2C-like cells in ESCs culture.
Figure supplement 2. Characterization of APH-induced 2C-like cells.
Figure supplement 3. Characterization of APH-induced 2C-like cells.
Atashpaz et al. eLife 2020;9:e54756. DOI: https://doi.org/10.7554/eLife.54756 4 of 30
Research article Cell Biology
sufficient to trigger Zscan4 expression (Storm et al., 2014). Finally, to evaluate the physiological rel-
evance of these findings in vivo, we asked whether transient induction of RS could activate the
expression of key 2C-embryo specific genes at the later stages of mouse embryonic development.
To this end, morula-stage embryos were treated with APH and subsequently, the synchronized
embryos were selected and subjected to RT-qPCR. Strikingly, induction of RS activated the expres-
sion of several key 2C-embryo specific markers, including Zscan4c, Dux, MERVL and Gm4981 in
mouse embryos (Figure 1g–j; Figure 1—figure supplement 3c–h; Figure 1—source data 1). Impor-
tantly, APH treatment did not disrupt the blastocyst formation or expression of ICM and TE markers
(Figure 1—figure supplement 3i–k).
Overall, these findings indicate that RS leads to the activation of 2C-embryo specific genes in
ESCs and morula-stage mouse embryos.
ATR and CHK1-mediated RS response triggers the activation of key 2C-
like genes in ESCs
Next, to gain further insight into the mechanisms through which RS response (RSR) could contribute
to the emergence of 2C-like cells in ESCs culture, we asked whether activation of the endogenous
DNA damage response pathways (DDR) is responsible for the emergence of 2C-like cells under nor-
mal culture condition. To this end, we inhibited DDR pathways by treating pZscan4-Emerald ESCs
with specific ATM and ATR inhibitors (ATMi, KU-55933 and ATRi, VE 822, respectively). FACS analy-
sis revealed a slight reduction in the number of Em+ cells upon ATR inhibition; however, treatment
with ATMi did not significantly reduce the fraction of Em+ cells in culture (Figure 2a; Figure 2—fig-
ure supplement 1a; Figure 2—source data 1). In addition, FACS analysis revealed a significant
enrichment of gH2AX+ and p-CHK1+ (indicators of RS) populations within Em+ ESCs (Figure 2—fig-
ure supplement 1 c and d; Figure 2—source data 1), suggesting that the transient activation of
ZSCAN4 is linked to the presence of endogenous RS in 2C-like cells. Consistent with these results,
inhibition of ATR but not ATM activity could robustly revert the expression of ZSCAN4 and Dux,
which was induced in response to various RS-inducing agents (e.g., UV, HU and APH) (Figure 2a and
b; Figure 2—figure supplement 1 a, b, e and f; Figure 2—source data 1). These results were fur-
ther validated on E14 and R1 ESC lines through RT-qPCR assay for Zscan4d and MERVL (Figure 2c;
Figure 2—figure supplement 1g; Figure 2—source data 1). Similar results were obtained in ATM
KO ESCs confirming that activation of APH-induced 2C-like genes in ESC culture is not ATM depen-
dent (Figure 2—figure supplement 1h–j; Figure 2—source data 1). Of note, inhibition of p38
MAPK signaling pathway did not lead to any decrease in the level of APH-induced 2C-gene expres-
sion. This result suggests that unlike the role of p38 inhibitors in suppressing DUX4 in cellular and
animal models of facioscapulohumeral muscular dystrophy (Oliva et al., 2019), this pathway does
not play a major role in the regulation of Dux upon RS induction in mouse ESC (Figure 2—figure
supplement 1k; Figure 2—source data 1).
In agreement with our findings, single cell transcriptional profiling revealed that suppression of
ATR activity by ATRi led to a statistically significant reduction in the number of cells that express
main 2C-genes in response to APH (e.g., Zscan4d+, Gm8300+, Gm022+, and Usp14ib+) (Figure 2d).
However, we did not find any significant change in the expression level of 2C-specific genes at the
single cell level across different conditions (i.e., CNTL, APH and APH+ATRi) (Figure 2—figure sup-
plement 1l–n). Moreover, FACS analysis of pMERVL-GFP ESCs did not show any significant increase
in the mean intensity of MERVL-GFP signal within MERVL+ population between CNTL and APH-
treated conditions (Figure 1—figure supplement 2g and h; Figure 1—source data 1). These results
suggest that the increase in the expression of 2C-genes upon APH treatment is mainly due to the
increase in the number of newly generated 2C-like cells and not to the overexpression of 2C-genes
in the pre-existing 2C-like cell population.
To further validate these findings, we derived ATR-deficient Seckel (AtrSec/Sec) and haploinsuffi-
cient (Chk1+/-) ESCs from previously reported mouse models (Liu et al., 2000; Murga et al., 2009)
as the complete ablation of ATR or CHK1 causes embryonic lethality in mice (Brown and Baltimore,
2000). To this end, ESC lines were established in culture using pre-implantation embryos obtained
from crosses between heterozygous mice either for Atr Seckel or for Chk1 KO alleles. On the basis
of genotyping results, homozygous Atr Seckel and heterozygous Chk1 ESC lines were characterized
for further investigations (Figure 2e and f; Figure 2—figure supplement 2a and b; Figure 2—
source data 1). Although immunoblot results confirmed that the levels of ATR and CHK1 proteins
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Figure 2. ATR and CHK1-mediated RSR triggers activation of key 2C-specific genes in ESCs. (a) FACS analysis on pZscan4-Emerald ESCs showing the
number of Em+ cells upon treatment with APH and specific ATR and ATM inhibitors. (b) Immunoblot for the phosphorylation status of key DDR kinases
(CHK1 and CHK2) and the ZSCAN4 protein level upon treatment with APH and ATM/ATR inhibitor in ESCs. (c) RT-qPCR analysis of two ESCs lines for
the expression of MERVL upon treatment with APH and ATRi. (d) Plot showing the scaled expression of 2C-specific markers and the percentage of cells
Figure 2 continued on next page
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were severely reduced in comparison to the wild type (WT) ESCs (Figure 2e and f; Figure 2—source
data 1), no significant alteration in the expression of key pluripotency genes was observed in AtrSec/
Sec or Chk1+/- ESCs compared to WT ESCs (Figure 2—figure supplement 2a and b). Noticeably,
similar to the inhibitory impact of ATRi on the expression of 2C-genes, APH treatment on AtrSec/Sec
ESCs led to only a mild increase in the expression of 2C-related genes unlike WT ESCs (Figure 2e
and g–k; Figure 2—figure supplement 2c–f; Figure 2—source data 1). As expected, similar results
were obtained with Chk1+/- ESCs and upon treatment with CHK1 inhibitor (CHK1i) (Figure 2f and l;
Figure 2—figure supplement 2g–n; Figure 2—source data 1). Of note, we did not find any alter-
ation in the level of APH-induced Dux upon Trp53 knockdown (KD) or its complete ablation in Trp53
KO ESCs, suggesting that activation of 2C-like pathway does not require the known mediator of
DDR, P53 (Figure 2—figure supplement 2o–r; Figure 2—source data 1).
Overall, these data indicate that the ATR and CHK1-stimulated response to RS regulates the acti-
vation of 2C-specific genes.
ATR induces the transcriptional signature of 2C-like cells in ESCs
Next, to understand whether activation of ATR-dependent response could result in a global tran-
scriptional activation of 2C-specific genes, we performed high-throughput transcriptional profiling
on three ESC lines, namely E14, R1 and MC1, upon APH treatment. Analysis of differentially
expressed genes (DEGs) (FDR < 0.05 and |log2 fold change| > 1) identified 3074 upregulated genes
with more than two-fold change in gene expression upon APH treatment, and only 640 downregu-
lated genes (Figure 3—figure supplement 1a; supplementary file 3), which is in agreement with
the general openness of chromatin in 2C-like cells (Ishiuchi et al., 2015). To understand how many
of the identified DEGs overlap with those specifically expressed in 2C-like cells, we compared our
list of APH-induced genes with a recently published dataset (Eckersley-Maslin et al., 2016).
Through such comparison, we found that a significant fraction of APH-induced retroviral elements
and genes overlap with those expressed in 2C-like cells, including MERVL, MT2_Mm, Dux, Eif1a-like
genes (Gm5662, Gm2022, Gm4027, and Gm8300), Zscan4 genes (Zscan4b and Zscan4d), Zfp352,
Zfp750, Tdpoz genes (Tdpoz1 and Tdpoz3), and Tmem92 (Figure 3a and b; Figure 3—figure sup-
plement 1b; supplementary file 4 and 5). Considerably, RT-qPCR results confirmed the significant
upregulation of main retroviral elements and 2C-specific genes upon APH treatment (Figure 3—fig-
ure supplement 1c–k; Figure 3—source data 1). Interestingly, the DEG analysis identified a large
portion (48%) of APH-induced 2C-specific genes to be transcriptionally repressed upon ATR inhibi-
tion (Figure 3c; supplementary file 4).
Recent reports demonstrated that 2C-like cells can be generated through genetic modulation of
several factors, including the KD of chromatin assembly factor-1 (CAF-1), KD of KRAB (Kruppel-Asso-
ciated Box Domain)-Associated Protein 1 (KAP1), KO of microRNA-34 (miR-34) and OE of DUX
(Choi et al., 2017; Ishiuchi et al., 2015; Hendrickson et al., 2017; Rowe et al., 2010). Thus, to test
whether these factors were involved in ATR-induced expression of 2C-related genes, we compared
the transcriptome of APH-induced ESCs with those from published datasets. While we found a sig-
nificant overlap with all datasets, the highest number of overlapping genes was found with the tran-
scriptome of CAF-1 KD ESCs (Figure 3—figure supplement 1l; supplementary file 4), possibly due
to the previously reported role of CAF-1 in preventing RS (Hoek and Stillman, 2003).
Figure 2 continued
expressing 2C-related genes in CNTL, APH-treated and APH+ATRi conditions. Fisher’s exact test was used to determine p-values. (e) Immunoblot for
ZSCAN4, ATR and the phosphorylation status of CHK1 upon APH treatment of AtrSec/Sec and Atr+/+ ESCs. (f) Immunoblot showing the expression of
ZSCAN4 and p-CHK1 in Chk1+/- and Chk1+/+ ESCs upon treatment with APH. (g–k) RT-qPCR for 2C-specific genes in AtrSec/Sec and Atr+/+ ESCs treated
with APH. (l) FACS analysis of pZscan4-Emerald ESCs showing the number of Em+ cells upon treatment with APH and a specific CHK1 inhibitor.
Statistical significance compared to CNTL unless otherwise indicated. All bar plots show mean with ± SD (*p0.05, **p0.01, ***p0.001,
****p0.0001, one-way ANOVA). For western blots quantification refer to Figure 2—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. FACS, qPCR and Western quantification.
Figure supplement 1. ATR-mediated RSR triggers activation of key 2C-specific genes in ESCs.
Figure supplement 2. ATR and CHK1-mediated RSR triggers activation of key 2C-specific genes in ESCs.
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Figure 3. ATR induces transcriptional signature of 2C-like cells in ESCs. (a) MA plot showing gene expression in ESCs treated with APH in comparison
to control. Key 2C-specific genes are highlighted (b) MA plot showing retrotransposons expression upon APH treatment. (c) Heatmap showing the
robust z-scores for 2C-specific genes in the indicated samples. 2C-related genes were identified by performing a differential expression analysis on
ZSCAN4+/MERVL+v.s. ZSCAN4-/ MERVL- ESCs from Eckersley-Maslin et al. (2016). (d) Bar plot displaying the percentage of ATR-dependent
Figure 3 continued on next page
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Next, to uncover the specific role of ATR in controlling 2C-genes regulating factors, we focused
our analysis on genes whose expression was reverted by ATRi. Remarkably, through such analysis we
found that 71% of the genes shared between APH and DUX-induced conditions were rescued by
ATRi (Figure 3d, supplementary file 4), suggesting a possible role of DUX in activation of 2C-spe-
cific genes through ATR. To validate this finding, we checked the expression of key 2C-related genes
in Dux KO ESCs after induction of RS. Importantly, although APH treatment, through ATR activation,
increased the expression of Dux and its downstream targets, such as Zscan4 and MERVL in WT
ESCs, it could not induce the expression of key 2C-genes in Dux KO ESCs (Figure 3—figure supple-
ment 2a–c; Figure 3—source data 1). Next, to understand whether the inability of APH in activating
MERVL and Zscan4 is due to a general suppression of these genes in Dux KO ESCs or not, we per-
formed a siRNA-mediated KD experiment to partially silence Dux in WT ESCs. As expected, upon
partial Dux KD in CNTL condition, the expression level of Zscan4 and MERVL decreased but was not
fully abolished (Figure 3—figure supplement 2d–f; Figure 3—source data 1). Consistent with our
previous findings, RT-qPCR results confirmed that the activation of ATR through APH treatment
increases the expression of 2C-genes in WT ESCs, while APH could only modestly activate Zscan4
and MERVL in Dux KD ESCs (Figure 3e–g; Figure 3—source data 1). These results were further vali-
dated by immunoblot for ZSCAN4 (Figure 3h; Figure 3—source data 1) and confirmed the role of
ATR in regulating 2C-genes through Dux activation.
Overall, these findings suggest that ATR is a potent upstream driver of 2C-genes expression in
ESCs.
ETAA1-mediated activation of ATR elevates the number of 2C-like cells
in a RS-free context
Recent evidence showed that ATR kinase can be directly activated by the RPA-binding protein,
Ewing’s tumor-associated antigen 1 (ETAA1) in the absence of RS (Bass et al., 2016; Haahr et al.,
2016). Hence, to confirm that the activation of 2C-specific genes is due to ATR-mediated response
and not the physical damage to DNA, we aimed to activate ATR in a DNA damage-free context
through overexpression of ETAA1-ATR activating domain (ETAA1-AAD) in ESCs. To this end,
pZscan4-Emerald ESCs were infected with two independent lentiviruses generated from two differ-
ent clones of ETAA1-expressing lentivectors in which ETAA1-AAD was expressed under the control
of a doxycycline (Dox)-inducible promoter, and subsequently the cells were selected against puromy-
cin and neomycin for two weeks. As expected, FACS analysis confirmed the activation of the ATR
pathway, as shown by an increase in the number of gH2AX+ cells upon Dox administration to
ETAA1-AAD-inducible ESCs (Dox-iETAA1 ESCs) compared to ESCs infected with an empty vector
(EV) (Figure 4—figure supplement 1a). However, ETAA1-AAD overexpression did not induce cell
apoptosis as shown by CASPASE-3 FACS analysis (Figure 4—figure supplement 1b). Strikingly,
ETAA1-AAD-stimulated activation of ATR was accompanied by a significant increase of the Em+
population in ESCs culture and transcriptional activation of Zscan4, Dux and MERVL (Figure 4a–d;
Figure 4—figure supplement 1 a and c-f; Figure 4—source data 1). As expected, this transcrip-
tional activation was fully abolished upon ATR and CHK1 inhibition (Figure 4a–c; Figure 4—figure
supplement 1f–j; Figure 4—source data 1).
Importantly, several lines of evidence demonstrated that the gH2AX positivity caused by the over-
expression of ETAA1 is not a consequence of DNA breakage (Bass et al., 2016; Haahr et al., 2016).
Consistent with this, ATR activation through ETAA1-AAD expression led to the mild phosphorylation
Figure 3 continued
differentially expressed genes among the ones shared between APH-treated ESCs and each dataset. (e–g) RT-qPCR analysis of Dux KD ESCs for Dux
and Zscan4d genes, and MERVL upon treatment with APH. (h) Immunoblot for p-CHK1 and ZSCAN4 proteins upon treatment with APH in Dux KD ESCs
in comparison with control ESCs. Statistical significance compared to CNTL unless otherwise indicated. All bar plots show mean with ± SD (*p0.05,
**p0.01, ***p0.001, ****p0.0001, one-way ANOVA). For western blots quantification refer to Figure 3—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 3:
Source data 1. qPCR and Western quantification.
Figure supplement 1. ATR induces transcriptional signature of 2C-like cells in ESCs.
Figure supplement 2. ATR induces transcriptional signature of 2C-like cells in ESCs.
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Figure 4. ETAA1-mediated activation of ATR induces 2C-like cells in a RS-free context. (a) FACS analysis for gH2AX and Emerald-GFP in Dox-iETAA1
ESCs in the presence or absence of Dox and upon treatment with ATRi or ATMi. (b) RT-qPCR results for Dux expression in Dox-iETAA1 ESCs upon Dox
induction in the presence or absence of ATRi or ATMi. (c) Immunoblot showing the expression of ETAA1-AAD, ZSCAN4, MERVL-GAG and the
phosphorylation status of CHK1, CHK2 and H2AX in Dox-iETAA1 ESCs upon treatment with Dox, ATRi or ATMi. (d) Immunoblot showing the expression
of ETAA1-AAD, ZSCAN4, MERVL-GAG in Dox-iETAA1 ESCs upon treatment with Dox and Dux knock down. (e–g) RT-qPCR analysis of Dox-iETAA1
Figure 4 continued on next page
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of H2AX and CHK1 but not CHK2 in ESCs (Figure 4a and c; Figure 4—source data 1). Moreover,
while inhibition of ATR activity reduced the level of gH2AX upon ETAA1-AAD-mediated activation of
ATR, inhibition of ATM activity did not exert any noticeable effect (Figure 4a and c; Figure 4—
source data 1). Finally, we demonstrated that the activation of canonical 2C-genes upon ETAA1-
AAD-mediated ATR activation is also DUX dependent, as Dux KD significantly reduced the ETAA1-
AAD-mediated expression of MERVL and ZSCAN4 (Figure 4d–g; Figure 4—figure supplement 2e–
h; Figure 4—source data 1). Similar results were obtained upon ETAA1-AAD-mediated ATR activa-
tion in Dux KO ESCs (Figure 4—figure supplement 1k–m; Figure 4—source data 1).
Finally, to further dissect the physiological role of ETAA1 in the transition to 2C-like state, we
asked whether its KD through specific siRNA (Figure 4—figure supplement 2a; Figure 4—source
data 1) could lead to a reduction in the level of 2C-specific genes expressed under basal condition.
Of note, the KD of ETAA1 did not lead to a reduction of 2C-genes expression (Figure 4—figure
supplement 2a-c; Figure 4—source data 1) in line with recent works where ETAA1 was found to
function in parallel to TOPBP1 in regulating ATR and maintaining genome stability (Bass et al.,
2016; Haahr et al., 2016). Moreover, we found a higher level of ETAA1 in 2C-like cells further con-
firming that activation of RSR pathways could lead to the expression of 2C genes (Figure 4—figure
supplement 2d).
These results collectively indicate that the DNA damage-independent, ETAA1-stimulated ATR
activation in ESCs is sufficient to activate 2C-related genes through DUX.
Candidate-based screening identifies the involvement of the GRSF1 in
the post-transcriptional regulation of the Dux mRNA downstream of
ATR
Next, to identify the mediating factors regulating Dux expression in response to ATR activation, we
performed a siRNA-based RT-qPCR screening using a library targeting 148 genes (Figure 5a) and
quantified the expression level of Zscan4, a bona fide DUX downstream target, as the final readout
(De Iaco et al., 2017; Hendrickson et al., 2017; Whiddon et al., 2017). To this aim, we took advan-
tage of the MISSION esiRNA technology that provides a heterogeneous mixture of siRNAs targeting
the same mRNA sequence, and thus offers a highly specific and effective gene-silencing approach at
lower concentration, ensuring a minimal risk of off-target effects (Theis and Buchholz, 2010). We
refined the list of siRNAs based on the overlap of the following categories: potential substrate of
ATR/CHK1 (Matsuoka et al., 2007; Blasius et al., 2011), Dux promoter-bound factors based on our
in silico analysis and previous findings (Campbell et al., 2018), and potential activators or suppres-
sors of Zscan4 (Figure 5b; Rodriguez-Terrones et al., 2018). We included siRNAs targeting Dux,
Atr, and Zscan4 as positive controls and a siRNA targeting Renilla luciferase as a negative control.
To identify Dux activators linked to ATR, we focused on genes whose KD could decrease the
APH-induced Zscan4 expression, while genes whose KD was sufficient to induce Zscan4 expression
were considered as Dux suppressors. Through analyzing RT-qPCR results, we identified 49 hits
whose downregulation altered Zscan4 expression at least two-fold. Interestingly, these genes were
found to be enriched in two main categories: i) genes involved in DNA replication and RSR such as
Vcp, Smc1a, Rfwd3, Rfc2 that further validated our finding on the involvement of RSR pathway in the
regulation of Dux; and ii) mRNA processing factors (Figure 5c; supplementary file 6), suggesting
the possible regulation of Dux at post-transcriptional level.
The significant enrichment of mRNA processing factors in our screening analysis, led us to test
whether ATR could directly affect Dux mRNA level. To this end, we first checked whether ATRi could
Figure 4 continued
ESCs for expression of 2C-related genes (Dux, MERVL and Zscan4) upon treatment with Dox and Dux knock down. Statistical significance compared to
CNTL unless otherwise indicated. All bar plots show mean with ± SD (*p0.05, **p0.01, ***p0.001, ****p0.0001, one-way ANOVA). For western
blots quantification refer to Figure 4—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 4:
Source data 1. qPCR and Western quantification.
Figure supplement 1. Characterization of ETAA1-AAD inducible ESCs.
Figure supplement 2. ETAA1-mediated activation of ATR induces 2C-like cells in a RS-free context.
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Figure 5. Identification of RSR downstream molecular players regulating the 2C-like state. (a.b) Schematic design
of the esiRNA-based knock-down screening and esiRNA library selection. (c) Protein interaction network for the
hits identified through the esiRNA screening. Activators and suppressors are highlighted in red and green,
respectively. The interactions are based on the STRING database. (d) RT-qPCR analysis of iDox-Dux ESCs for
exogenous Dux mRNA upon treatment with Dox. (e) RT-qPCR analysis of iDox-Luciferase ESCs for Luciferase
mRNA upon treatment with Dox. (f) RT-qPCR analysis of Dux mRNA upon APH treatment and Grsf1 KD. (g)
Immunoblot showing the expression of GRSF1, ZSCAN4 and pCHK1 upon Gsrf1 KD. (h) Immunoblot showing the
Figure 5 continued on next page
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alter the level of Dux mRNA produced exogenously by a vector that did not contain Dux natural pro-
moter. To verify this, we treated Dux overexpressing ESCs, generated by the stable integration of a
Dox-inducible Dux construct into ESCs (Dox-iDux ESCs), with ATRi and probed the level of exoge-
nous Dux transcript using oligos specifically recognizing this construct. While Dox administration led
to a remarkable increase in the level of exogenous Dux mRNA, ATR inhibition significantly reduced
the Dox-induced Dux transcript (Figure 5d; Figure 5—source data 1). Similar results were obtained
upon Atr KD, however, neither ATRi nor Atr KD could dramatically alter the levels of exogenous
Luciferase mRNA induced by Dox administration (Figure 5e; Figure 5—source data 1). Finally, to
exclude any possible effect of ATR inhibition on endogenous Dux gene expression, we generated a
Dox-inducible Dux OE system using Dux KO ESCs in which the endogenous Dux genomic region
was completely deleted (De Iaco et al., 2017), and obtained a similar result on the expression of
endogenous Dux mRNA upon ATR inhibition (Figure 5—figure supplement 1a; Figure 5—source
data 1). Importantly, Dux overexpression did not lead to a significant increase in the level of
p-CHK1, ruling out the possibility of DUX activating RSR pathway through the ATR-CHK1 axis (Fig-
ure 5—figure supplement 1b; Figure 5—source data 1). Overall these results suggest that ATR
affects the level of Dux mRNA through its post-transcriptional regulation.
Next, to identify the potential Dux mRNA-binding factor(s) through which ATR could alter Dux
mRNA level, we performed RNA-protein pull-down using a synthetic 3’ untranslated region of Dux
mRNA (Dux 3’UTR). Mass-spectrometry analysis of the pulled-down proteins revealed several Dux
3’UTR binding factors, including RNA binding proteins HNRNPA1, HNRNPA3, HNRNPA2B1,
PABPN1, PABPC1, PCBP1, PCBP2 and GRSF1 (supplementary file 7). Strikingly, although both
Grsf1 and Pcbp2 KD could reduce APH-induced Dux expression (Figure 5f and g; Figure 5—figure
supplement 1c; Figure 5—source data 1), only GRSF1, which belongs to a group of heterogeneous
nuclear RNPs bearing the RNA-recognizing domain RRM (Ufer, 2012), was proven to bind Dux
3’UTR by immunoblot (Figure 5h; Figure 5—source data 1). These results suggest that GRSF1 is
directly binding and likely stabilizing Dux mRNA. Importantly, we did not observe any alteration in
the level of pCHK1 upon Grsf1 KD (Figure 5g; Figure 5—source data 1), excluding the possibility
of Dux modulation through induction of RS in GRSF1-deficient cells. Of note, GSRF1 has been found
to be phosphorylated in putative ATR and CHK1 sites following cellular stress in mass spectrometry
based phospho-proteomic screens (Mertins et al., 2014), suggesting that direct phosphorylation by
ATR/CHK1 might affect its function in Dux regulation. Although further studies will be required to
explain the specific role of GRSF1 in the post-transcriptional regulation of Dux through ATR, these
findings shed light on the link between RSR and Dux regulation. Furthermore, they support recent
observations reporting the involvement of mRNA processing factors in the regulation of 2C-genes
(Rodriguez-Terrones et al., 2018).
ATR-activated ESCs gain expanded developmental potential
Our results so far indicated that ATR-activated ESCs exhibit similar transcriptional profile and charac-
teristics of 2C-like cells. These findings led us to ask whether ATR-activated ESCs also gain
expanded developmental potential similar to 2C-like cells, which are able to contribute to both
embryonic and extra-embryonic tissues (Choi et al., 2017; Ishiuchi et al., 2015; Macfarlan et al.,
2012).
To test this hypothesis, both AtrSec/Sec and Atr+/+ ESCs were cultivated in the absence or in the
presence of APH and were subsequently differentiated in vitro toward trophoblast-like stem cells
(TSCs) for three days, followed by terminal differentiation to TGCs upon withdrawal of fibroblast
growth factor 4 (FGF4) and heparin for additional three days (Figure 6a; Abad et al., 2013). The RT-
Figure 5 continued
binding of GRSF1 protein to the Dux mRNA. Statistical significance compared to CNTL unless otherwise indicated.
All bar plots show mean with ± SD (*p0.05, **p0.01, ***p0.001, ****p0.0001, one-way ANOVA). For western
blots quantification refer to Figure 5—source data 1.
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. qPCR and Western quantification.
Figure supplement 1. mRNA processing factors regulate the level of Dux transcript.
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Figure 6. ATR-activated 2C-like cells gain expanded developmental potential in vitro and in vivo. (a) Phase contrast and immunofluorescence images of
TGCs formed by in vitro differentiation of Atr+/+ or Atrsec/sec ESCs treated with or without APH (bar = 25 mm). (b) Quantification of the number of TGCs
detected in the conditions represented in a. (c) Images of blastocysts displaying the contribution of mCherry-labeled Dox-iETAA1 ESCs to the ICM and
TE layers in the presence and absence of Dox (bar = 20 mm). (d) Bar plot showing the percentage of chimeric embryos in which injected mCherry-
Figure 6 continued on next page
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qPCR results for the TGC specific marker, Prl2c2, revealed the highest expression in ATR-activated
conditions, while AtrSec/Sec cells could not significantly up-regulate this gene in the presence of APH
(Figure 6—figure supplement 1a; Figure 6—source data 1). Moreover, Prl2c2 basal level was sig-
nificantly higher in WT cells compared to non-treated AtrSec/Sec cells (Figure 6—figure supplement
1a; Figure 6—source data 1). These results were also consistent with the expression of Placenta-
Expressed Transcript one protein (PLET1) and the number of TGCs generated in each condition
(Figure 6a and b; Figure 6—source data 1). Next, to understand whether ATR-induced differentia-
tion to TGCs is also mediated by DUX, we differentiated Dux KO and WT ESCs toward trophoblast
cells upon ATR activation (Figure 6—figure supplement 1b). Significantly, ATR activation in Dux KO
cells could not induce the formation of TGCs unlike WT cells, confirming the critical role of DUX in
trophoblast-directed differentiation program upon ATR activation (Figure 6—figure supplement
1c; Figure 6—source data 1). These experiments indicate that the transition to 2C-like state is
required for ATR-induced TGC differentiation.
Next, to define the cell fate potential of ATR-activated ESCs during embryonic development, we
traced the fate of their progenies in chimeric blastocysts. To this end, ten mCherry fluorescent pro-
tein–labeled (mCherry-labeled) Dox-iETAA1 ESCs were treated with Dox and subsequently microin-
jected into each C57BL/6N recipient mouse morulae. Untreated Dox-iETAA1 ESCs were injected in
parallel as control. The contribution of ESCs to the inner cell mass (ICM) and the trophectoderm (TE)
layer of the blastocysts was then monitored 48 hr post-injection (Figure 6c). While both Dox-treated
and untreated ESCs contributed to the ICM, strikingly, upon ATR activation, we found a statistically
significant (Fisher’s exact test p-value: 0.0005) increase in the number of chimeric embryos in which
ESC progenies localized to both ICM and TE (Figure 6d; Figure 6—figure supplement 1d).
Although the basal contribution level of untreated ESCs to the TE could be due to the previously
reported effect of 2i (Morgani et al., 2013), overexpression of ETAA1-AAD significantly increased
the number of embryos in which mCherry-labelled cells could contribute to the TE. Next, we asked
whether activation of ATR through ETAA1-AAD expression is also able to impact on the number of
cells contributing to the TE layer of the blastocyst. To this aim, we repeated this experiment and
compared the number of cells in the TE layer of embryos injected upon Dox treatment to the one
observed in CNTL. Significantly, ATR activation was able to increase about two-fold the average
number of cells contributing to the TE layer (Figure 6—figure supplement 1e; Figure 6—source
data 1). Finally, to understand whether ATR-dependent expanded developmental potential is medi-
ated by DUX, we generated mCherry-labeled ETAA1-AAD Dox-inducible ESCs in a Dux KO back-
ground. As shown in Figure 4—figure supplement 1k–m, unlike WT cells that increased the
expression of 2C-genes upon Dox treatment, Dux KO ESC were not able to activate these genes.
Importantly, through the mouse chimera assay we found that activation of ATR was not able to sig-
nificantly increase the number of mCherry-labeled Dox-iETAA1 Dux KO ESCs contributing to TE
Figure 6 continued
labeled Dox-iETAA1 ESCs could contribute to either ICM or ICM+TE with or without Dox. The ratios on top of each bar show the actual number of
embryos that were analyzed. (e) Bar plot showing the percentage of chimeric embryos in which single-cell injection of mCherry-labeled Dox-iETAA1
ESCs could contribute to either ICM or ICM+TE/TE with or without Dox. The ratios on top of each bar show the actual number of embryos
that were analyzed. (f) Images showing the contribution of injected mCherry-labeled Dox-iETAA1 ESCs to the epiblast (EPI) or extra-embryonic layers
(EEL) of mouse embryos at E7.5 with or without Dox treatment (bar = 50 mm). (g) Immunostaining of mouse embryos at E7.5. Arrows in the left panel
indicate the contribution of mCherry-labeled Dox-iETAA1 ESCs to the EPI (marked by POU5F1) in Dox-treated and untreated conditions. Arrows in the
right panel indicate the contribution of injected mCherry-labeled Dox-iETAA1 ESCs to the EEL (marked by CDX2) only in Dox-treated condition. (lower
magnification, bar = 100 mm, higher magnification, bar = 25 mm). (h) Schematic model defining a novel ATR-dependent transcriptional response to
maintain the genomic integrity of developing embryos in response to RS. 1) ATR and CHK1-mediated RSR triggers the Dux mRNA accumulation
through GRSF1 that in turn increases bipotent 2C-like cells by global transcriptional activation of 2C-specific genes including Zscan4. 2) ATR-induced
bipotent ESCs extend their contribution to placental compartment. In the dot plot the mean is represented by a red line. Statistical significance
compared to CNTL unless otherwise indicated. (*p0.05, **p0.01, ***p0.001, ****p0.0001, one-way ANOVA).
The online version of this article includes the following source data and figure supplement(s) for figure 6:
Source data 1. qPCR and TGCs quantification, and TE contribution counting.
Figure supplement 1. ATR-activated 2C-like cells gain expanded developmental potential.
Figure supplement 2. ATR-activated 2C-like cells gain expanded developmental potential.
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layer upon Dox treatment, consistent with our in vitro results (Figure 6—figure supplement 1f; Fig-
ure 6—source data 1).
The expanded cell fate potential of RS-induced ESCs could originate from cells with bidirectional
potential or a heterogeneous population containing cells that preferentially differentiate into embry-
onic or extraembryonic lineages (Choi et al., 2017). To distinguish between these two possibilities,
we microinjected a single mCherry-labeled Dox-iETAA1 ESC upon Dox treatment into each C57BL/
6N recipient morulae to generate chimeric blastocysts. Consistent with our previous findings, a con-
siderable number of ATR-activated single cells were able to contribute to ICM+TE or TE, albeit with
lower efficiency (Fisher’s exact test p-value: 0.08) (Figure 6e; Figure 6—source data 1). To further
validate these observations, we generated post-implantation chimeric embryos by microinjecting ten
mCherry-labeled Dox-iETAA1 ESCs into each C57BL/6N morulae that were subsequently transferred
to foster mothers. While WT ESCs contributed exclusively to the embryonic tissue (epiblast), ATR-
activated cells contributed to both embryonic and extra-embryonic cell lineages in 50% (3 out of 6)
of chimeric embryos at embryonic day (E) 7.5 (Figure 6f and g; Figure 6—figure supplement 1g;
Figure 6—figure supplement 2a and b). These results indicate that ATR-activated ESCs gain
expanded developmental potential, in contrast to ESCs, which are mostly restricted to generate
embryonic cell types (Figure 6h).
These findings overall indicate that ATR-activated ESCs gain expanded developmental potential
in vitro and in vivo, and that this effect is mediated by DUX, whose physiological role in the activa-
tion of cleavage-stage transcription program has been reported in previous works (De Iaco et al.,
2017; Hendrickson et al., 2017; Whiddon et al., 2017).
Discussion
The physiological relevance of the 2C-like transcriptional program has been limited to 2C-stage
embryos, and thus the molecular regulation involved in reactivation of 2C-like cells in ESCs culture
and its possible significance in vivo at later stages of embryonic development have remained elusive.
Here, we provide evidence that transition to bipotent 2C-like cells in ESCs culture is triggered by
activation of ATR, a developmentally essential DDR gene, which plays a crucial role in the mainte-
nance of stem cells both in embryonic and adult tissues (Brown and Baltimore, 2000;
Ruzankina et al., 2007). First, we found a significant enrichment of gH2AX+ and p-CHK1+ cells
within Em+ cell population. Second, inhibition of RSR by specific ATR or CHK1 inhibitors, but not
p38 inhibitors, could markedly reduce the number of 2C-like cells in ESCs culture. Third, ATR-defi-
cient Seckel and haploinsufficient CHK1 ESCs exposed to RS could not significantly induce 2C-spe-
cific genes. Fourth, activation of ATR through ETAA1-AAD overexpression could further increase the
population of bipotent 2C-like cells in ESCs culture in the absence of RS. Finally, through a candi-
date-based screen approach, we unraveled the mechanistic basis of ATR-stimulated transition to
bipotent 2C-like cells by showing that this response induces a 2C-like transcriptional program
through post-transcriptional regulation of Dux, the key inducer of zygotic genome activation (ZGA)
in placental mammals (De Iaco et al., 2017; Hendrickson et al., 2017; Whiddon et al., 2017).
Importantly, although DNA damage-induced cellular differentiation has been frequently shown in
stem cells (Santos et al., 2014; Schneider et al., 2013), here we report for the first time to our
knowledge that RS in ESCs leads to the transition to a more developmentally potent state that is
required for the subsequent differentiation toward TGCs. As far as the molecular mechanism of
ATR-dependent Dux level increase is concerned, our results show that ATR activity is required to
promote Dux mRNA accumulation at the post-transcriptional level. This finding is consistent with
previous observations showing that the mRNA processing machinery can regulate DUX4 mRNA level
by promoting its degradation (Feng et al., 2015). Significantly, we discovered that GRSF1, a RNA
binding protein involved in several aspects of mRNA metabolism (Ufer, 2012), directly and specifi-
cally binds to Dux mRNA and it is required for Dux mRNA accumulation in response to ATR activa-
tion. The links between GRSF1 and Dux are unexpected and will require further work to be fully
dissected.
Elevated DUX level in turn increases bipotent 2C-like cells in ESC culture through global transcrip-
tional activation of 2C-specific genes, including genome caretaker genes, Zscan4 and Tcstv1/
3 (Zhang et al., 2016; Zalzman et al., 2010). In addition to their role in telomere elongation through
activation of telomere sister chromatid exchange (Nakai-Futatsugi and Niwa, 2016; Zalzman et al.,
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2010), Zscan4 genes can also promote DNA repair by facilitating heterochromatin decondensation
and DNA demethylation (Akiyama et al., 2015; Eckersley-Maslin et al., 2016; Dan et al., 2017).
Therefore, ATR-mediated activation of Zscan4 genes likely contributes to ESCs genomic integrity in
response to RS. Intriguingly, the DUX4 genes were originally discovered in an attempt to identify the
target genes of Helicase-like Transcription Factor (HLTF) (Ding et al., 1998), that was later found to
act at replication forks upon RS (Peng et al., 2018). Unexpectedly, our findings also show that ATR
activation in ESCs can trigger the generation of cells with bidirectional cell fate potential
(Figure 6h). Activation of this pathway could act as a safeguard mechanism to ensure genome integ-
rity of the developing embryo in response to RS by promoting DNA repair, on the one hand, or by
diverting unrepaired ATR-activated ESCs to extra-embryonic tissues, on the other hand, thus limiting
the incorporation of cells with unrepaired DNA in embryo proper tissues. These findings could in
part explain the phenotype of Atrsec/sec mouse embryo, in which failure in proper activation of ATR
in response to RS leads to the accumulation of gH2AX positive cells in embryo proper (Murga et al.,
2009).
Overall our findings revealed that 1) ATR is a potent upstream driver of 2C-specific genes in ESCs
culture; 2) 2C-like transcriptional program can also be activated at later stages of embryonic devel-
opment (rather than being activated only at 2C-embryo stage) in response to exogenous RS; 3) 2C-
like state induced by RS and ATR influences ESC fate and impacts on its plasticity and likely genome
integrity. These findings suggest that the physiological role of 2C-like transcriptional program might
not only be restricted to ZGA. Importantly, ATR-/- mice have been reported to develop up to
the blastocyst stage (Brown and Baltimore, 2000; de Klein et al., 2000), suggesting that presence
of ATR may not play an essential role in ZGA at 2C-stage embryo. This would be consistent with a
recent finding showing that Dppa2 and Dppa4, which are expressed until the onset of gastrulation,
were found to be the direct regulators of DUX-driven zygotic transcriptional program (Eckersley-
Maslin, 2018). This behavior would be compatible with the reactivation of 2C-like transcriptional
program at later stages of development, concomitantly with a weakening of the suppressive mecha-
nisms that keep 2C-genes repressed in response to endogenous or exogenous stimuli. However,
although our findings indicate that ATR activation impacts on the cell fate even at later stages of
embryonic development, we also clearly show that RS per se is not able to trigger main 2C-genes in
more committed embryonic cells such as MEFs, suggesting an involvement of robust repressive
mechanisms in suppressing this pathway in more differentiated cells.
It is tempting to speculate that reactivation of such ATR-dependent transcriptional program in
more committed adult stem cells in which these suppressive mechanisms fail, could be responsible
for the expression of genes that are involved in invasiveness, angiogenesis and immunosuppression
shared by placenta and cancer cells (Costanzo et al., 2018; Ferretti et al., 2007). This would be
consistent with the recently reported Dux/DUX4 reactivation in a diverse range of tumors
(Yasuda et al., 2016; Yoshimoto et al., 2017; Preussner et al., 2019). In line with this, a recent
report has shown that DUX4 level increases specifically in cancer cells, promoting their ability to
downregulate major histocompatibility complex I antigen presenting molecules (Chew et al., 2019),
a feature shared between trophoblast and cancer cells that allows escaping from immune surveil-
lance mechanisms (Costanzo et al., 2018). Activation of extraembryonic features in response to ATR
in early stages of cellular transformation could be a major outcome of RS induced by oncogene
activity in cancer cells and would provide an additional rationale for the potent tumor suppressive
effect of ATR inhibitors (Costanzo et al., 2018; Bartek et al., 2012; Bartkova et al., 2005;
Dobbelstein and Sørensen, 2015; Macheret and Halazonetis, 2015; Nieto-Soler et al., 2016).
Intriguingly, extraembryonic tissues have been recently shown to have similar epigenetic methylation
profiles to cancer cells (Smith et al., 2017), highlighting an additional common feature between
these two tissues.
In summary, our findings shed light on the endogenous and exogenous stimuli that could contrib-
ute to the cellular plasticity of ESCs and also provide a fundamental insight into the alternative
mechanisms these cells exploit to respond to RS and maintain genome integrity.
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Materials and methods
Animals
All mice used to generate ATR Seckel ESCs and MEF lines were bred and maintained under specific
pathogen-free conditions. C57Bl/6J and 129P2/OlaHsd mice were purchased from Charles River
Laboratories Harlan Italy (currently known as Envigo), respectively. Animals were kept in ventilated
cages in standard 12 hr light-dark cycle.
Cell culture
ESCs were grown in feeder-free culture condition and incubated at 37˚C under 3% O2 tension. ESC
medium composed of KnockOut DMEM (ThermoFisher, 10829–018), 15% ESC qualified Fetal Bovine
Serum (ThermoFisher, 16141–079), 2 mM L-glutamine, 1/500 home-made leukemia inhibitory factor
(LIF), 0.1 mM non-essential amino acids, 0,1 mM 2-mercaptoethanol, 50 units/mL penicillin, 50 mg/
mL streptomycin supplemented with the two inhibitors (2i); PD 0325901 (1 mM) and CHIR 99021 (3
mM) was used. MEFs were cultured in high glucose DMEM (Lonza, BE12-614F) supplemented with
10% North American FBS, 2 mM L-glutamine, 0.1 mM non-essential amino acids, 50 units/mL penicil-
lin, 1 mM Sodium Pyruvate and 50 mg/mL streptomycin (MEF medium).
ESCs derivation from ATR seckel and CHK1 haploinsufficient mice
To establish AtrSec/Sec ESCs, Atr+/Sec heterozygous mice were crossed. Morulae were recovered and
cultured overnight in KSOM medium (Millipore, MR-020P-5D) under mineral oil. Blastocysts were
placed on MEFs feeder layer in ESC medium with 2i and LIF at 37˚C under 5% CO2. Upon ICM
expansion, cells were passaged on feeder layer to obtain the first stock. The cells were then charac-
terized by genotyping. To establish Chk1+/- ESCs lines, embryos at morula stage were cultured over-
night in KSOM supplemented with 2i. On the following day, blastocysts were plated individually in
96-well plate and cultured in N2B27 medium supplemented with 2i and LIF. After 6–7 days, the ICM
outgrowth was disaggregated using Accutase. Clumps of cells were expanded every second day, or
when the size of colonies reached to the proper expansion level.
MEFs generation
To produce MEFs, C57BL/6 and 129P2/OlaHsd mice were used. MEFs were prepared by mechanical
disaggregation, trypsinization and seeding of embryos (E12-E13) in MEF medium after removal of
the head, tail, limbs, and internal organs. Each trypsinized embryo was plated into a 10 cm dish.
Once cells reached to 90% confluency (after 48 hr), they were frozen and stocked for the subsequent
experiments.
Treatments
All treatments, including APH, HU, UV, ATRi, ATMi, p38i and CHK1i, were added into fresh ESC
medium and the cells were kept at 37˚C under 3% O2 tension overnight (16–17 hr) unless otherwise
indicated. APH was used at concentrations ranging from 0.4 to 6 mM as indicated. Similarly, HU was
used at 0.1 mM - 0.2 mM. ATMi (KU-55933) and ATRi (VE 822) were used at the concentrations of
10 mM and 1 mM respectively. The CHK1 inhibitors LY2603618 and UCN-01 were used at the concen-
trations of 200 nM and 100 nM, respectively. UV radiation exposure was performed at the dosage of
5 J/m2 or 10 J/m2. For induction of ETAA1-AAD expression, Dox was used at the concentration of 1
mg/mL for 48 hr. SB 203580 hydrochloride (Tocris Bioscience) and SB 239063 (Tocris Bioscience)
were used at the concentration of 5 and 10 mM.
RNA extraction, cDNA synthesis and qPCR
RNA was extracted using RNeasy Mini Kit (QIAGEN, 74104) and quantified by spectrophotometer
(NanoDrop, ThermoFisher) after removal of DNA contaminants by DNAse I digestion (QIAGEN,
79254). cDNA was prepared from 2 mg of total RNA using SuperScript III reverse transcriptase kit
(ThermoFisher, 18080–044) with Oligo(dT)20 Primer (ThermoFisher, 18418–020) and dNTP Mix
(ThermoFisher, 18427–013) following manufacturer’s instructions. qPCR assay was performed based
on standard protocol using final working concentration of 1X SsoFast EvaGreen Supermix (Bio Rad,
1725201) or 1X LightCycler 480 SYBR Green I Master (Roche, 04707516001), 0.5 mM primer mix and
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5 ng of cDNA. GAPDH, TBP or GUSB were used as internal controls to normalise the qPCR data fol-
lowing the DDCt method. For the list of oligos used in this study please refer to the
Supplementary file 8.
RNA isolation from embryos and cDNA preparation
Cryopreserved C57BL/6N morulae purchased from Janvier Labs (QUICKBLASTO), were thawed
according to the manufacturer’s protocol. After recovery, a group of healthy morulae were treated
with APH at final concentration of 1.5 mM in KSOM culture medium for 4 hr while the rest were kept
as control. The day after, the same number of morphologically healthy and synchronized blastocysts
(22 and 7 blastocysts in the 1st and 2nd round, respectively) were selected from both groups. The
APH concentration and the treatment interval had no effect on the viability of the embryos. RNA iso-
lation was performed based on the previously published works (Eckersley-Maslin, 2018;
Costanzo et al., 2018). Briefly, following the removal of zona pellucida in acidic tyrode’s solution
(Sigma-Aldrich, T1788), the pool of embryos was collected in 10 ml of lysis buffer containing 5X First
Strand Buffer (from SuperScript III reverse transcriptase kit, ThermoFisher) supplemented with 0.1%
Tween-20. Subsequently, embryos were mechanically ruptured by three cycles of freeze/thaw. As
the quantity of isolated RNA is not detectable by NanoDrop spectrophotometer, the supernatant
was directly used for cDNA preparation following centrifugation at 10621 g for 2 min. cDNA prepa-
ration and qPCR were performed following the aforementioned protocols.
Flow cytometry (FACS)
ESCs were fixed and permeabilized using Cytoperm/Cytofix kit (BD Biosciences, 554714), and subse-
quently stained for 1 hr at room temperature with anti-H2AX-Phosphorylated (Ser139) antibody con-
jugated with Alexa Fluor 647 (Biolegend, 613407, RRID:AB_2114994), or Anti-p-CHK1 antibody
conjugated with PE (Cell Signaling, 12268, RRID:AB_2797863) or Anti-ZSCAN4 (Merck Millipore,
AB4340, RRID:AB_2827621) antibody conjugated with Anti-Rabbit ALexa488. Cells were washed
and acquired on a FACSCalibur instrument (BD Biosciences, RRID: SCR_000401) or Attune NxT
(Thermo Fisher Scientific). For Emerald, mCherry and GFP acquisition, cells were trypsinized, col-
lected and subsequently acquired without fixation. Cell cycle profiles were acquired after incubation
with DAPI (4’,6-diamidino-2-phenylindole) overnight.
Immunocytochemistry
Briefly, cells were fixed in 4% formaldehyde (Sigma-Aldrich) for 20 min and subsequently blocked for
1 hr in 10% FBS and 0.1% Triton-X100. Then, cells were incubated with primary antibody at 4˚C over-
night, followed by washes and incubation with secondary antibodies for 1 hr at room temperature.
Next, samples were mounted and images were acquired with wide-field fluorescence microscope
(Olympus AX70, Olympus). Acquired images were analyzed by ImageJ software (NIH, RRID:SCR_
003070). For staining mouse embryos, blastocysts were fixed in 4% formaldehyde, followed by per-
meabilization for 10 min in 0.5% Triton X-100 and blocking for 1 hr at room temperature in 3% BSA
and 0.1% Tween-20 in PBS. Then blastocysts were incubated with primary antibodies at 4˚C over-
night, before washes in 0.1% BSA in PBS and secondary antibodies incubation for 2 hr at room tem-
perature, followed by a 15 min incubation with DAPI. Stained blastocysts were imaged with Leica
TCS SP2 AOBS inverted confocal microscope.
Antibodies used in this study were Anti-Oct-3/4 (Santa Cruz, sc-5279, RRID:AB_628051), Anti-
Nanog (Abcam, ab80892, RRID:AB_2150114), Anti-GFP (Abcam, ab5450, RRID:AB_304897), Anti-
Plet-1 (Nordic MUbio, MUB1512P, RRID:AB_2827622), Anti-Cdx2 (Biocare Medical ACI 3144B,
RRID:AB_2827623), Anti-mCherry (ChromoTek 5F8 a-RFP, RRID:AB_2336064.), Anti-ZSCAN4 (Merck
Millipore, AB4340, RRID:AB_2827621), Anti-MERVL-GAG (Huabio, ER50102, RRID:AB_2636876),
Anti-ETAA1 (Abcam, ab197017, RRID:AB_282762).
Immunoblotting
Cells were trypsinized and washed with PBS and then lysed for 30 min on a rotating wheel at +4˚C in
RIPA buffer supplemented with protease/phosphatase inhibitor cocktail (Cell Signaling, 5872).
Lysates were sonicated with a Bioruptor Sonication System (UCD200) at high power for 3 cycles of
30 s with one minute breaks. Lysates were centrifuged at 13000 rpm for 20–30 min and clear
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supernatants were transferred to new tubes. Protein content was quantified using Bio-Rad protein
assay according to manufacturer’s instructions. For the detection of each protein, 35 mg of total pro-
tein extracts were loaded. Standard western blot was performed using following antibodies: Anti-
ATR (Cell Signaling, 2790, RRID:AB_2227860), Anti-p-CHK1 (S317) (cell signaling, 12302, RRID:AB_
2783865), Anti-ZSCAN4 (Merck Millipore, AB4340, RRID:AB_2827621), Anti-CHK1 (Santa Cruz,
8408, RRID:AB_627257), Anti-CHK2 (Millipore, 05–649, RRID:AB_2244941), Anti-gH2AX (Merck Milli-
pore, 05–636, RRID:AB_309864), Anti-P53 (Cell Signaling, 2524S, RRID:AB_331743), Anti-p-P53
(S15) (Cell Signaling, 12571S, RRID:AB_2714036.), Anti-GAPDH (Abcam, ab9484, RRID:AB_307274),
Anti Oct-3/4 antibody (Santa Cruz, sc-5279, RRID:AB_628051), Anti-VINCULIN (Sigma, V9131, RRID:
AB_477629), Anti-ATM (Sigma, A1106, RRID:AB_796190), Anti-GRSF1 (Abcam, AB246330, RRID:
AB_2827628.), Anti-PCBP2/hnRNP E2 (Abcam, AB236137, RRID:AB_2827629.), Anti-MERVL-GAG
(Huabio, ER50102, RRID:AB_2636876), Anti-ETAA1 (Abcam, ab197017, RRID:AB_282762), Anti-
SOX2 (Chemicon International, AB5603, RRID:AB_2286686).
Drop-seq single cell mRNA sequencing
ESCs from CNTL, APH (6 mM) and APH-ATRi experimental conditions were resuspended in PBS-BSA
and processed with a microfluidic device according to the DropSeq Laboratory Protocol V3.1 from
McCarroll’s Lab website [http://mccarrolllab.com/dropseq/]. For each condition, three distinct ali-
quots of collected emulsion, each containing 4000 beads underwent reverse transcription (RT) and
fragment library preparation using Illumina Nextera XT Library Prep Kit. A distinct barcode was used
for each library to allow subsequent demultiplexing of sequencing reads. mRNA sequencing was
performed using an Illumina HiSeq2000 instrument, library fragments were sequenced at 50 base
pairs (bp) in PE mode. Sequencing reads were aligned to UCSC Mouse Reference Genome version
mm10 using STAR (version 2.5.3a), and processed according to DropSeq Alignment Cookbook V1.2
to generate a digital expression matrix of STAMPs (cells) for each experimental condition, which was
then furtherly analyzed in the RStudio environment (R version 3.3.3, RRID:SCR_00432) using Seurat
package V2.0 from Satija Lab [http://satijalab.org/seurat/] (RRID:SCR_007322). Seven-hundred highly
expressing cells were selected in each condition; genes expressed in less than 3 cells and cells
expressing less than 200 genes were pruned from the dataset. Data from CNTL and APH conditions
(1399 cells) or CNTL, APH and APH-ATRi conditions (2096 cells) were merged to generate two data-
sets, which were log normalised and scaled. Expression mean and variance to mean ratio
(LogVMR >0.5) were used to estimate data dispersion and select variable genes across the dataset.
Respectively 2614 and 2768 genes (in the 2-conditions and 3-conditions datasets) were used in prin-
cipal component analysis (PCA) to identify the appropriate number of components to include in data
modeling. Top 15 components were selected to explain dataset complexity. A shared nearest neigh-
bor (SNN) graph and smart local moving algorithm was used to perform cells clustering; t-SNE (t-sto-
chastic neighbor embedding) analysis was used to reduce (PCA) dimensionality and generate plots
of cells distribution.
RNA sequencing library preparation and sequencing
RNA samples were quantified using Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA, USA)
and RNA integrity was checked with RNA Screen Tape on Agilent 2200 TapeStation (Agilent Tech-
nologies, Palo Alto, CA, USA). All RNA samples had a RIN score of 10. Ribo-Zero rRNA Removal Kit
and TruSeq Stranded Total RNA library Prep kit was used to generate barcoded fragment libraries
for RNA sequencing, following manufacturer’s protocol (Illumina, Cat# RS-122–2101). Briefly, rRNA
depleted RNAs were fragmented for 8 min at 94˚C. First strand and second strand cDNA were sub-
sequently synthesized. The second strand of cDNA was marked by incorporating dUTP during the
synthesis. cDNA fragments were adenylated at 3’ends, and indexed adapters were ligated to cDNA
fragments. Limited cycle PCR was used for library enrichment. The incorporated dUTP in second
strand cDNA quenched the amplification of second strand, which helped to preserve the strand
specificity. Sequencing libraries were validated using DNA Analysis Screen Tape on the Agilent 2200
TapeStation (Agilent Technologies, Palo Alto, CA, USA), and quantified by using Qubit 2.0 Fluorom-
eter (Invitrogen, Carlsbad, CA) as well as by quantitative PCR (Applied Biosystems, Carlsbad, CA,
USA).
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Barcoded libraries were normalized, pooled and loaded on a single flowcell’s lane of Illumina
HiSeq4000 (RRID:SCR_016386) sequencer for cluster generation and sequencing, according to man-
ufacturer’s instructions. The samples were sequenced using a 2  150 Pair-End (PE) High Output
configuration. Image analysis and base calling were conducted by the HiSeq Control Software (HCS)
on the HiSeq instrument. Raw sequence data (.bcl files) generated from Illumina HiSeq was con-
verted into FASTQ files and de-multiplexed using Illumina bcl2fastq program version 2.17. One mis-
match was allowed for index sequence identification. On average ~29 million reads were generated
for each sample and average insert size ranged between 204–231 for different libraries.
RNA sequencing data processing
Transcript and gene level quantification was done with Kallisto (version 0.43.0) (Bray et al., 2016).
The RefSeq (RRID: SCR_003496) NM and NR sequence collection as of 2016-11-21, was used to
build the transcriptome index. Kallisto (RRID: SCR_016582) was run with the –bias option to per-
form sequence based bias correction on each sample. Additionally, all reads were mapped with the
STAR spliced aligner (version 2.5.2b) (RRID: SCR_015899) (Dobin et al., 2013) to the GRCm38
(mm10) genome after trimming the reads to 100 bp with Trimmomatic (version 0.36) (RRID: SCR_
011848) (Bolger et al., 2014). Repeat expression was quantified by counting fragments overlapping
with the repeat annotation from Choi et al. (2017), using FeatureCounts (RRID: SCR_012919) from
the subread package (version 1.5.2) (Liao et al., 2014). FeatureCounts was run with the –p –B –C –
primary options.
RNA sequencing: gene level differential expression
Read counts for each sample estimated by Kallisto were imported into the R statistical environment
(version 3.2.2) using tximport (version 1.1.2) (Soneson et al., 2015) (RRID: SCR_016752). The limma
(version 3.24.15) (RRID: SCR_010943) package (Ritchie et al., 2015) was used to test for differential
expression between CNTL and APH or CNTL and APH+ATRi treatments after TMM normalization
and voom transformation (Liao et al., 2014). A linear model was fitted with the limma lmFit function
and the moderated t-statistics was calculated with the eBayes function. Genes were defined as dif-
ferentially expressed if they had FDR adjusted p-values<0.05 and |log2 fold change| > 1.
The robust z-score for each gene in each sample was calculated using the median and mean
absolute deviation (MAD) for each gene across samples, and standardizing expression with the fol-
lowing formula:
Robust Z   score ¼ x  medianð Þ=MAD where x is the expression in TPM for a single gene in a
given sample.
RNA sequencing repeat analysis
Read counts for each sample based on the STAR (RRID:SCR_015899) alignment were imported into
the R statistical environment (version 3.2.2) and summarized on the repeat subfamily level. edgeR
(version 3.14.0) (RRID: SCR_012802) (McCarthy et al., 2012) was used to test for differential expres-
sion between CNTL and APH treatments, after TMM normalization. All repeat subfamilies were
dropped where the count per million value did not reach one in at least two samples. A linear model
was fitted with the edgeR glmFit function and a likelihood ratio p-value was calculated with the
glmLRT function. Repeat subfamilies were defined as differentially expressed if they had FDR
adjusted p-values<0.05 and |log2 fold change| > 1.
RNA sequencing gene set enrichment analysis
Gene set enrichment was calculated using a mouse version of MSigDB (RRID:SCR_016863) available
from http://bioinf.wehi.edu.au/software/MSigDB/ (Accessed September 12, 2016). The CAMERA
method (Wu and Smyth, 2012) available in the limma package was used to check for significant
enrichment of specific gene sets between the CNTL and APH treatments, using the same TMM nor-
malized read counts as in the gene differential expression analysis. Additionally, the GSVA
(Ha¨nzelmann et al., 2013) package was used to transform gene level read counts per sample to a
gene set level enrichment score per sample and for each MSigDB gene set. After this, the same
limma analysis was carried out on the gene set enrichment values as for the gene level data. Gene
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sets were defined as differentially expressed if they had FDR adjusted p-values<0.05 and |log2 fold
change| > 0.5.
Gene set enrichment for the Control and Dox treatment or Control and Dux KD+Dox treatment
was calculated with the ROAST method available in the limma (version 3.24.15) package
(Ha¨nzelmann et al., 2013; Wu et al., 2010).
RNA sequencing literature comparison
For all of the literature comparisons, the same transcript and gene level quantification methods and
transcriptome annotations were used as for our data using the same limma package and methods to
define differentially expressed genes between conditions. The Fisher-test was used to check for the
significance of the overlaps in differentially expressed genes between our data and the literature
datasets.
Transcription factor binding site prediction
To predict transcription factor binding sites in the Dux promoter region, we extracted the promoter
sequence around the Dux transcription start site (TSS), with 1000 nucleotides upstream and 100
nucleotides downstream of the TSS. We submitted this sequence to the JASPAR database (RRID:
SCR_003030), and predicted putative binding sites using the JASPAR CORE set (Khan et al., 2018).
We filtered out predicted binding sites with a score <5, and ranked the putative transcription factors
regulating Dux based on the total number of binding sites predicted.
Transfection
ESCs were plated in 2i plus LIF medium as described above with or without antibiotics according to
the applied Lipofectamine (RNAiMAX or 2000, respectively). Lipofectamine (Sigma-Aldrich) was
diluted in Opti-MEM (ThermoFisher) according to the manufacturer’s protocol and incubated for 5
min at room temperature. siRNAs and MISSION esiRNAs (Sigma-Aldrich) were diluted in Opti-MEM
to the opportune concentration and then added to the Lipofectamine emulsion at 1:1 ratio. Follow-
ing incubation at room temperature (timing depends on the type of Lipofectamine), the mixture was
added to the cells suspension in culture medium. The final concentration of Dux and Trp53 siRNAs
were 75 nM and 40 nM, respectively and the final concentration of MISSION esiRNAs were 60 nM.
For each experiment a sample was transfected with MISSION siRNA Fluorescent Universal Negative
Control, Cyanine 5 (for siRNA transfection) or esiRNA targeting RLUC (for MISSION esiRNA transfec-
tion) as negative controls at the same concentration used for the siRNA or esiRNA of interest. Gene
expression was assessed 48 hr post transfection.
Cloning, lentivirus production and induction
pLVX-EF1a-IRES-mCherry vector was co-transfected with plasmids encoding POL, REV, TAT, and
the vesicular stomatitis virus envelope glycoprotein (VSV-G) into 80% confluent 293 T cells (RRID:
CVCL_0063) using calcium phosphate precipitation in the presence of 25 mM chloroquine. The
supernatant of transfected cells was collected every 24 hr for two days and concentrated using PEG-
itTM virus precipitation solution and viral particles were resuspended in DMEM and frozen in small
aliquots at  80˚C.
The Lenti-XTM Tet-On 3G Inducible Expression System was used to express ETAA1-AAD protein
in ESCs. The cDNA of ETAA1-AAD (kind gift from Mailand lab, Novo Nordisk Foundation Center for
Protein Research, Copenhagen, Denmark) was cloned in pLVX-TRE3G vector. Viral particles of pLVX-
TRE3G-ETAA1-AAD and pLVX-EF1a-Tet3G vectors were separately produced (as mentioned above).
ESCs were co-infected with both lentiviruses in the presence of 8 mg/mL polybrene, and subse-
quently infected cells were subjected to puromycin and neomycin selection for two weeks. To induce
ETAA1-AAD expression, selected ESCs were treated with 1 mg/mL Dox for 48 hr. To generate Dux
and luciferase overexpressing ESCs, pCW57.1-Luciferase (RRID:Addgene_99283) and pCW57.1-
mDux-CA (RRID:Addgene_99284) plasmids were used for lentivirus production.
siRNA-based screening
The esiRNA screening was performed on Tecan Freedom EVO 200 Automated workstation (Tecan
Group Ltd., Switzerland, RRID:SCR_016771), equipped with RoMa (Robotic Manipulator Arm) and
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LiHa (Liquid Handling Arm) with 1 ml dilutors. Briefly, ESCs were reversely transfected with esiRNAs
and Lipofectamine RNAiMAX (Invitrogen 56532) in 96-well plates. Subsequently, cells were treated
with APH or ATRi 36 hr post-transfection. Twelve hours after treatment, cell proliferation was
assessed by CyQUANT Cell Proliferation Assay kit (ThermoFisher C35011), followed by cell lysis
using Cells-to-CT Kit (ThermoFisher, AM1728). The Taqman qPCR assays were performed using Bio-
mek FXP Automated Workstation (Beckman Coulter Life Sciences).
In vitro differentiation and analysis
ESCs were differentiated toward TSC and TGCs as previously reported (Abad et al., 2013;
Tanaka et al., 1998; Ng et al., 2008). Briefly, ATR Seckel or Dux KO ESCs along with WT ESCs
were seeded on gelatin-coated 6-well plate in ESCs medium and 24 hr post treatment, medium was
changed to trophoblast stem cell (TSC) differentiation medium, which contains: 30% RPMI 1640
(Lonza, BE12-167F) supplemented with 20% FBS, 1 mM pyruvate, 2 mM L-glutamine, 100 mM b-
mercaptoethanol), 70% of conditioned medium from mitomycin-C-inactivated fibroblasts, 25 ng/mL
FGF4 (R and D Systems, 235-F4-025) and 1 mg/mL heparin (Sigma-Aldrich, H3149). The medium was
refreshed daily to maintain TSCs. To induce giant cell differentiation, TSCs were split at day two on
gelatin-coated plate. After 24 hr, medium was changed to RPMI 1640 with 20% FBS, 1 mM pyruvate,
2 mM L-glutamine, 100 mM b-mercaptoethanol in the absence of heparin and FGF4. The medium
was changed daily for 3 days.
Mouse chimera assay
Mouse chimera assays were conducted at University of Copenhagen. Morulae were obtained from
superovulated C57BL/6 prepubescent females. One (single cell experiments,) five (E4.5 embryos) or
ten (E7.5 embryos) ESCs were injected into each morula after piercing their zona pellucida with bev-
eled microinjection needle. Embryos were kept in M2 medium during the injection and afterwards in
KSOM medium at 37˚C under 5% CO2. Morulae were either cultured for 48 hr to study ESC contribu-
tion at late blastocyst stage (E4.5), or transferred to pseudopregnant females and later dissected at
E7.5. ESC contribution to the various embryonic layers were assessed by the localization of mCherry
fluorescence signal.
For the APH-treated ESCs, frozen morula-stage embryos were purchased from Charles River and
Janvier laboratories. Embryos were thawed 2 hr prior to injection and 4 to 8 ESCs were transferred
into the perivitelline space by laser-assisted microinjection method. Afterwards, embryos were cul-
tured for 24 hr at 37˚C, 5% CO2 until blastocyst stage (E3.5).
RNA-pull down
RNA-pull down was performed using Pierce Magnetic RNA-Protein Pull-Down Kit (ThermoFisher,
20164) following provider’s instruction using Dux 3’UTR synthetic RNA.
Liquid chromatography–tandem MS (LC–MS/MS) analysis
The entire gel lane was processed with STAGE-diging protocol as described by Soffientini et. al.
(Soffientini and Bachi, 2016). The entire protocol occurs in a p1000 tip (Sarstedt 70.762.100) filled
at the orifice with a double C18 Empore Disk (3M, Minneapolis, MN) plug, named STAGE-diging tip.
Briefly, after Coomassie staining, the entire lane was carefully cut into ~1 mm3 cubes and transferred
into the STAGE-diging tip. These gel cubes were dehydrated with 100% acetonitrile (CAN, Carlo
Erba 412392000) and rehydrated in 100 mM NH4HCO3 (Sigma A-6141) twice before being dehy-
drated by the addition of ACN. To ensure that the gel pieces do not create a sticky surface on the
C18, all the solutions were added with a gel-loader tip. The removal of solutions was accomplished
by centrifugation at 1800 rpm using the commercial tip box as holder. Reduction of protein disulfide
bonds was carried out with 10 mM dithiothreitol (DTT, Nzytech MB03101) in 100 mM NH4HCO3 and
subsequent alkylation was performed with 55 mM iodoacetamide (IAA Sigma I1149-25G), in com-
plete darkness, in 100 mM NH4HCO3, at room temperature for 30 min. Both DTT and IAA were
removed by centrifugation or by syringe as previously described. The gel pieces were rehydrated
and dehydrated with 100 mM NH4HCO3 and ACN respectively prior to digestion. Gel pieces were
rehydrated with 40 mL of Trypsin (12.5 ng/mL in 100 mM NH4HCO3, after few minutes 60 mL of
NH4HCO3 were added and samples were incubated at 37˚C o/n in a commercial tip box filled by
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water on the bottom to ensure that buffer will not evaporate. The digestion solution was then forced
through the double plug with a syringe and the flow through was collected. Samples were acidified
with 100 mL of formic acid (FA, Fluka 94318) 0.1%, forced with the syringe and collected as flow-
through to desalt the peptides. Peptides were eluted twice by adding 100 mL of a solution com-
posed of 80% ACN, 0.1% FA, an extra step of extraction with 100% ACN was performed and then
all the eluates were dried in a Speed-Vac and resuspended in 12 mL of solvent A (2% ACN, 0.1% for-
mic acid). Four mL were injected for each technical replicate on the Q-Exactive –HF mass
spectrometer.
Mass spectrometry analysis
Mass spectrometry analysis was carried out by LC–MS–MS on a quadrupole Orbitrap Q Exactive HF
mass spectrometer (Thermo Scientific). Peptide separation was achieved on a linear gradient from
95% Solvent A to 50% Solvent B (80% acetonitrile, 0.1% formic acid) over 20 min and from 50% to
100% Solvent B in 2 min at a constant flow rate of 0.25 ml minutes  1 on a UHPLC Easy-nLC 1000
(Thermo Scientific), where the LC system was connected to a 25 cm fused-silica emitter of 75 mm
inner diameter (New Objective), packed in house with ReproSil-Pur C18-AQ 1.9 mm beads (Maisch)
using a high-pressure bomb loader (Proxeon). MS data were acquired using a data-dependent
top15 method for HCD fragmentation. Survey full scan MS spectra (300–1750 Th) were acquired in
the Orbitrap with 60,000 resolution, AGC target 1e6, IT 120 ms. For HCD spectra the resolution was
set to 15,000, AGC target 1e5, IT 120 ms; normalized collision energy 28 and isolation width 3.0 m/
z. Two technical replicates of each sample were carried out.
Protein identification
For protein identification, the raw data were processed using Proteome Discoverer (version
1.4.0.288, Thermo Fischer Scientific). MS (Ahuja et al., 2016) spectra were searched with Mascot
engine (RRID: SCR_014322) against uniprot_mouse_ database (80894 entries), with the following
parameters: enzyme Trypsin, maximum missed cleavage 2, fixed modification carbamidomethylation
(C), variable modification oxidation (M) and protein N-terminal acetylation, peptide tolerance 10
ppm, MS/MS tolerance 20 mmu. Peptide Spectral Matches (PSM) were filtered using percolator
based on q-values at a 0.01 FDR (high confidence). Proteins were considered identified with two
unique high confident peptides (Ka¨ll et al., 2007). Scaffold (version Scaffold_4.3.4, Proteome Soft-
ware Inc, Portland, OR, RRID:SCR_014345) was used to validate MS/MS based peptide and protein
identifications. Peptide identifications were accepted if they could be established at greater than
95.0% probability by the Peptide Prophet algorithm (Keller et al., 2002) with Scaffold delta-mass
correction. Protein identifications were accepted if they could be established at greater than 99.0%
probability and contained at least two identified peptides. Protein probabilities were assigned by
the Protein Prophet algorithm (RRID:SCR_000286) (Nesvizhskii et al., 2003). Proteins that contained
similar peptides and could not be differentiated based on MS/MS analysis alone were grouped to
satisfy the principles of parsimony. Proteins sharing significant peptide evidence were grouped into
clusters.
b-Galactosidase staining
b-Galactosidase staining was performed following provider’s instruction (Cell Signaling Technology,
9860).
Ethics statement
The use and care of mice as described in this study was approved by the FIRC Institute of Molecular
Oncology Institutional Animal Care and Use Committee in compliance with Italian law (D.lgs. 26/
2014 and previously D.lgs. 116/92), which enforces Dir. 2010/63/EU (Directive 2010/63/EU of the
European Parliament and of the Council of 22 September 2010, on the protection of animals used
for scientific purposes) and by the Italian Ministry of Health experimental license 471/2015-PR.
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0201-00928 granted by the Danish Animal Inspectorate to A.J.L.C. All animal studies were per-
formed in compliance with internationally accepted standards.
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